MetaCap

Lite Strategy Inc. Company Profile

NASDAQ: LITSHealthcareBiotechnologyUSD

1.22-0.05 (-3.94%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Lite Strategy at a glance

Lite Strategy Inc. (NASDAQ: LITS) is a Biotechnology company in the Healthcare sector headquartered in San Diego, CA. Lite Strategy employs about 5 people. The company's shares have traded publicly since 2003.

At a market capitalization of $37.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001262104, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Lite Strategy do?

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Lite Strategy Inc.
Ticker
NASDAQ: LITS
Industry
Biotechnology
Employees
5
Headquarters
9920 Pacific Heights Blvd., San Diego, CA, United States
Phone
858 369 7100
IPO year
2003
Market cap
$37.10M
SEC CIK
0001262104
Latest annual report
10-K · Sep 28, 2026

Companies similar to Lite Strategy

LITS peer companies
CompanyPrice% ChgMarket capCompare
MGXMetagenomi Therapeutics Inc.0.9932+0.86%$37.52Mvs LITS
IBOImpact BioMedical Inc.4.11-8.26%$35.11Mvs LITS
FLNAFilana Therapeutics Inc.0.8136-0.26%$39.30Mvs LITS
CVMCel-Sci Corporation1.95-8.45%$34.30Mvs LITS
GRDXGridAI Technologies Corp.4.80+16.50%$34.23Mvs LITS
BCTXBriaCell Therapeutics Corp.3.92-2.00%$34.10Mvs LITS
ATNMActinium Pharmaceuticals Inc. (Delaware)1.08+0.93%$33.96Mvs LITS
NNVCNanoViricides Inc.1.31-9.03%$33.44Mvs LITS

Related